An HSV-2 positive result means your blood test detected antibodies to herpes simplex virus type 2, the primary cause of genital herpes. This tells you that your immune system has encountered the virus at some point, whether or not you’ve ever had visible symptoms. An estimated 520 million people aged 15 to 49 worldwide (about 13%) carry HSV-2, making it one of the most common sexually transmitted infections on the planet.
What the Test Numbers Mean
The standard HSV-2 blood test measures IgG antibodies, which your body produces weeks to months after infection and retains long-term. Results are reported as an index value:
- Negative: 0.9 or below
- Equivocal: 0.9 to 1.0 (borderline, needs retesting)
- Positive: 1.1 or above
Here’s an important nuance: not all positive results are equally reliable. Index values between 1.1 and 3.0 are considered “low positive” and carry a higher rate of false positives. Research in the Journal of Clinical Microbiology found that samples in this range have the highest percentage of false positive results across multiple testing platforms. The CDC recommends a two-step process for these cases: the initial screening test followed by a second, more specific confirmatory test. If your index value falls in this low-positive zone, it’s worth requesting that confirmatory test before drawing any conclusions.
An index value above 3.5 is highly likely to be a true positive.
Why You Might Have No Symptoms
Many people who test positive for HSV-2 have never noticed an outbreak, and this is completely typical. The virus can live in nerve cells near the base of the spine without ever producing visible blisters. When symptoms do appear, the incubation period ranges from one to 26 days after initial infection, though six to eight days is most common. Some people don’t experience their first noticeable outbreak until months or years after they were initially infected.
When outbreaks do occur, they typically involve fluid-filled blisters on the genitals, anus, or surrounding skin. These blisters break open, form shallow sores, and then crust over and heal, usually within two to four weeks for a first episode. Recurrent outbreaks tend to be shorter and milder. HSV-2 causes more frequent recurrences than HSV-1 in the genital area, and the rate of both outbreaks and invisible viral shedding tends to decrease over the first year of infection.
Viral Shedding Without Symptoms
Even without visible sores, the virus periodically reactivates and reaches the skin surface. A study published in JAMA found that people with asymptomatic HSV-2 infection shed the virus on about 10% of days, and 84% of that shedding happened without any noticeable signs. People who do get visible outbreaks shed the virus on roughly 13% of days. This invisible shedding is a major reason HSV-2 spreads so effectively: most transmission happens when the carrier doesn’t know they’re contagious.
Reducing Transmission Risk
Consistent condom use lowers the risk of passing HSV-2 to a partner by about 30%. That’s meaningful but far from complete protection, because the virus can shed from skin areas that a condom doesn’t cover. Daily antiviral suppressive therapy further reduces both the frequency of outbreaks and the amount of viral shedding, which is why many people with HSV-2 take a daily antiviral if they have a partner who is HSV-2 negative. Combining condoms with daily antivirals offers the strongest risk reduction currently available.
Avoiding sexual contact during active outbreaks or when you feel prodromal symptoms (tingling, itching, or burning in the area where sores usually appear) also helps, since viral load is highest during these periods.
Treatment Options
There’s no cure for HSV-2, but antiviral medications effectively manage it. Treatment falls into two categories:
- Episodic therapy: Taking antivirals at the first sign of an outbreak to shorten its duration and severity.
- Suppressive therapy: Taking a daily antiviral to reduce outbreak frequency and lower the chance of transmitting the virus to a partner.
The most commonly prescribed antivirals are valacyclovir (Valtrex), acyclovir (Zovirax), and famciclovir (Famvir). These medications work by blocking the virus’s ability to replicate. They’re generally well tolerated and can be taken long-term. Many people on suppressive therapy experience few or no outbreaks while taking medication daily.
HSV-2 and Pregnancy
If you’re pregnant or planning to become pregnant, an HSV-2 positive status requires some extra planning but is very manageable. Neonatal herpes occurs in roughly 1 in 3,200 deliveries in the United States. The vast majority of mother-to-child transmission (about 85%) happens during delivery, not during pregnancy itself.
The risk depends heavily on timing. A brand-new genital herpes infection acquired late in pregnancy carries a transmission risk as high as 57%, because the mother hasn’t yet built up protective antibodies. For women with a history of recurrent outbreaks, the risk during delivery drops to about 2%. Starting antiviral suppressive therapy at 36 weeks of gestation reduces the likelihood of active lesions at delivery and decreases the need for cesarean section.
If active genital lesions or prodromal symptoms are present when labor begins, cesarean delivery is recommended. Women with a history of genital herpes but no active lesions at the time of delivery can deliver vaginally.
What HSV-2 Means for Your Overall Health
For most people, HSV-2 is a manageable skin condition, not a serious health threat. Outbreaks tend to become less frequent and less severe over time, especially in the first few years after infection. The virus does not damage internal organs or shorten life expectancy in otherwise healthy individuals.
One health consideration worth knowing: HSV-2 infection can increase susceptibility to acquiring HIV if exposed, because the micro-breaks in skin caused by herpes (even during invisible shedding) create entry points. This doesn’t mean you’re at imminent risk, but it’s one reason reducing viral shedding through suppressive therapy has benefits beyond outbreak control.
The emotional weight of a positive HSV-2 result often exceeds the medical reality. The infection is extremely common, highly treatable, and for many people, causes no symptoms at all. Understanding what the diagnosis actually involves, and what tools exist to manage it, tends to make the biggest difference in how people adjust.